These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25937473)

  • 1. Overgrowth syndromes with vascular anomalies.
    Blei F
    Curr Probl Pediatr Adolesc Health Care; 2015 Apr; 45(4):118-31. PubMed ID: 25937473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized overgrowth syndromes with prenatal onset.
    Yachelevich N
    Curr Probl Pediatr Adolesc Health Care; 2015 Apr; 45(4):97-111. PubMed ID: 25861999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G; Chang F; Li MM
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
    Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Herrera-Garcia JD; Luque-Valenzuela M; Sanchez-Cano D; Lopez-Gutierrez JC; Ruiz-Villaverde R; Tercedor-Sanchez J
    Clin Genet; 2017 Jan; 91(1):14-21. PubMed ID: 27426476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How we approach complex vascular anomalies and overgrowth syndromes.
    Watson KD; Kim KR; Blatt J
    Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29273. PubMed ID: 36070209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular malformations syndromes: an update.
    Martinez-Lopez A; Salvador-Rodriguez L; Montero-Vilchez T; Molina-Leyva A; Tercedor-Sanchez J; Arias-Santiago S
    Curr Opin Pediatr; 2019 Dec; 31(6):747-753. PubMed ID: 31693582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.
    Keppler-Noreuil KM; Rios JJ; Parker VE; Semple RK; Lindhurst MJ; Sapp JC; Alomari A; Ezaki M; Dobyns W; Biesecker LG
    Am J Med Genet A; 2015 Feb; 167A(2):287-95. PubMed ID: 25557259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overgrowth syndromes with vascular malformations.
    Hagen SL; Hook KP
    Semin Cutan Med Surg; 2016 Sep; 35(3):161-9. PubMed ID: 27607325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
    J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overgrowth syndromes with complex vascular anomalies.
    Uller W; Fishman SJ; Alomari AI
    Semin Pediatr Surg; 2014 Aug; 23(4):208-15. PubMed ID: 25241100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
    Luks VL; Kamitaki N; Vivero MP; Uller W; Rab R; Bovée JV; Rialon KL; Guevara CJ; Alomari AI; Greene AK; Fishman SJ; Kozakewich HP; Maclellan RA; Mulliken JB; Rahbar R; Spencer SA; Trenor CC; Upton J; Zurakowski D; Perkins JA; Kirsh A; Bennett JT; Dobyns WB; Kurek KC; Warman ML; McCarroll SA; Murillo R
    J Pediatr; 2015 Apr; 166(4):1048-54.e1-5. PubMed ID: 25681199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum.
    Yeung KS; Ip JJ; Chow CP; Kuong EY; Tam PK; Chan GC; Chung BH
    Am J Med Genet A; 2017 Apr; 173(4):978-984. PubMed ID: 28328134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular anomalies: molecular bases, genetic testing and therapeutic approaches.
    Paolacci S; Zulian A; Bruson A; Manara E; Michelini S; Mattassi RE; Lee BB; Amato B; Bertelli M
    Int Angiol; 2019 Apr; 38(2):157-170. PubMed ID: 30938497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for vascular anomalies.
    Kirkorian AY; Grossberg AL; Püttgen KB
    Semin Cutan Med Surg; 2016 Sep; 35(3):128-36. PubMed ID: 27607321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Aspects of the Segmental Overgrowth Spectrum Due to Somatic Mutations in PIK3CA.
    Kang HC; Baek ST; Song S; Gleeson JG
    J Pediatr; 2015 Nov; 167(5):957-62. PubMed ID: 26340871
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and sonographic features of pediatric soft-tissue vascular anomalies part 2: vascular malformations.
    Johnson CM; Navarro OM
    Pediatr Radiol; 2017 Aug; 47(9):1196-1208. PubMed ID: 28779187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on classification and diagnosis of vascular malformations.
    McCuaig CC
    Curr Opin Pediatr; 2017 Aug; 29(4):448-454. PubMed ID: 28654575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum.
    Chen H; Gao W; Liu H; Sun B; Hua C; Lin X
    Ann Plast Surg; 2023 May; 90(5S Suppl 2):S209-S215. PubMed ID: 36729078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral sildenafil as a treatment option for lymphatic malformations in PIK3CA-related tissue overgrowth syndromes.
    Horbach SE; Jolink F; van der Horst CM
    Dermatol Ther; 2016 Nov; 29(6):466-469. PubMed ID: 27502552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA vascular overgrowth syndromes: an update.
    Hughes M; Hao M; Luu M
    Curr Opin Pediatr; 2020 Aug; 32(4):539-546. PubMed ID: 32692051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.